BEONE MEDICINES LTD. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BEONE MEDICINES LTD. stock issued during period, value, stock options exercised for the quarter ending 2020-09-30 was $1.00K, a 99.99% decline year-over-year.
- BEONE MEDICINES LTD. stock issued during period, value, stock options exercised for the quarter ending 2020-06-30 was $16.57M, a 278.89% increase year-over-year.
- BEONE MEDICINES LTD. stock issued during period, value, stock options exercised for the quarter ending 2020-03-31 was $11.63M, a 85.50% increase year-over-year.
- BEONE MEDICINES LTD. stock issued during period, value, stock options exercised for the quarter ending 2019-09-30 was $9.74M, a 5.20% decline year-over-year.
- BEONE MEDICINES LTD. stock issued during period, value, stock options exercised for fiscal 2020 was $1.00K, a 100.00% decline from fiscal 2019.
- BEONE MEDICINES LTD. stock issued during period, value, stock options exercised for fiscal 2019 was $47.00M, a 58.47% increase from fiscal 2018.
- BEONE MEDICINES LTD. stock issued during period, value, stock options exercised for fiscal 2018 was $29.66M, a 541.06% increase from fiscal 2017.
- BEONE MEDICINES LTD. stock issued during period, value, stock options exercised for fiscal 2017 was $4.63M, a 31.49% increase from fiscal 2016.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2020-12-31 | $1.00K 10-K · filed 2023-02-27 | |
| 2020-09-30 | $1.00K 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $16.57M 10-Q · filed 2020-11-05 | |
| 2020-03-31 | $11.63M 10-Q · filed 2020-11-05 | |
| 2019-12-31 | $47.00M 10-K · filed 2020-03-02 | |
| 2019-09-30 | $9.74M 10-Q · filed 2020-11-05 | $29.19M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $4.37M 10-Q · filed 2020-11-05 | $29.72M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-03-31 | $6.27M 10-Q · filed 2020-11-05 | $29.62M derived: sum of 4 quarters · filed 2020-11-05 |
| 2018-12-31 | $8.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $29.66M 10-K · filed 2020-03-02 |
| 2018-09-30 | $10.28M 10-Q · filed 2019-11-12 | $23.91M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $4.27M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $6.31M 10-Q · filed 2019-11-12 | |
| 2017-12-31 | $3.05M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $4.63M 10-K · filed 2020-03-02 |
| 2016-12-31 | $3.52M 10-K · filed 2019-02-28 |